Evaluation of the Effects of Simvastatin 40 Mg on Lipid Profiles and Specified Circulatory Parameters in Normotensive Hypercholesterolemia Patients(MK-0733-265)
Phase of Trial: Phase IV
Latest Information Update: 27 Jan 2016
At a glance
- Drugs Simvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck & Co
- 06 Jan 2016 Study phase has been changed from III to IV as reported by ClinicalTrials.gov record.
- 01 Feb 2007 Status changed from recruiting.
- 24 Nov 2006 New trial record.